Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?

@article{Park2016IsCO,
  title={Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?},
  author={Hae-Jeong Park and Kyubo Kim and Jin Ho Paik and Eui Kyu Chie and S Kim and J-Y Jang and S W Kim and S S Han and D-Y Oh and S A Im and T Y Kim and Y. -J. Bang and Sung W Ha},
  journal={Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
  year={2016},
  volume={18 6},
  pages={625-31}
}
PURPOSE To analyze the expression of c-Met, and to investigate correlations between the expression of c-Met, clinicopathologic variables, and survival in patients undergoing curative surgery followed by adjuvant chemoradiotherapy for extrahepatic bile duct (EHBD) cancer. METHODS Ninety EHBD cancer patients who underwent curative resection followed by… CONTINUE READING